
Akso Health Group: financial statements
Price
$1.24
November 20, 2026Market cap $896M
What Ploutos Investor adds for Akso Health
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from FY2017
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Financial statements
Each fiscal year's income statement, balance sheet and cash flow as the company filed them, and the latest quarters.
Click a line to see it on the chart.
Revenue
| Line | FY2024 | FY2025 | FY2026 | Average a year |
|---|---|---|---|---|
| Revenue | $2.4M | $15M | $14M | |
| Cost of revenue | $2.3M | $15M | $14M | |
| Gross profit | $122.1K | -$281.5K | -$11.3K | |
| Operating income | -$8.6M | -$166M | -$21M | |
| Net income | -$9.5M | -$135M | -$19M | |
| Earnings per share | -$0.21 | -$0.48 | $0.03 | |
| Earnings per share, basic | -$0.21 | -$0.48 | $0.03 | |
| Margins | ||||
| Gross margin | 5.1% | -1.9% | -0.1% | |
| Operating margin | -357.8% | -1,125.4% | -149.7% | |
| Net margin | -391.8% | -913.4% | -135.0% | |
Financial statements
AHG's revenue, profits and cash flows from FY2017 to FY2023, 7 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
By segment
Revenue and operating income by business segment or by product, as the company itself reports them in each year's 10-K. Each year from the latest filing that carries it, so a segment renamed or re-cut shows in its current form.
- Health Devices
- Online Market Place
- FY2022: Health Devices $6.0M, Online Market Place $311.1K
| Segment | FY2022 | Share FY2022 |
|---|---|---|
| Health Devices | $6.0M | 95% |
| Online Market Place | $311.1K | 4.9% |
From the XBRL of 9 of the company's annual reports to the SEC (ASC 280). Amounts in dollars.
Amounts are in dollars as the company filed them in its annual reports (10-K or 20-F). Those reporting in another currency are converted at each fiscal year-end rate. Shares and earnings per share are adjusted for splits.
Per-share figures are per quoted ADS, which stands for 3 of the company's ordinary shares; the filings count per ordinary share.
Debt and obligations
What the company owes beyond the loans on its balance sheet, and when it pays, from the notes to its annual report: debt maturities, leases, pension plans, goodwill by segment, and how it gets to the tax it pays.
Leases
Mar 31, 2026Operating leases
$25.1K
Finance leases
–
The liability is the present value of the rent still to pay, at March 31, 2026. It is not counted in the ladder's debt. The filing
Goodwill by segment
Mar 31, 2025Total goodwill
$11M
The company does not state its goodwill by segment, at March 31, 2025. Impairment in the year: $41M.The filing
From the statutory to the effective tax rate, FY2026
Mar 31, 2026Statutory rate
25.0%
Effective rate
-9.6%
The company paid -9.6% in tax on its profit, 34.6 points below the statutory rate it starts from (25.0%). Below, the reasons it gives.
The lines the company states do not reach its effective rate, so we do not show them. Both rates are the filing's. The filing
The full analysis
What do Akso Health's filings show?
These are Akso Health's figures from its filings. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
How much revenue did AHG have in FY2026?
Akso Health had revenue of $14M and net income of -$19M in fiscal FY2026, a net margin of -135.0%.
How much debt does AHG have?
On March 31, 2026 Akso Health had total assets of $190M, debt of – and shareholders' equity of $181M.
How much free cash flow does AHG have?
In fiscal FY2026 Akso Health had cash from operations of -$13M and spent $1.6K on capital expenditure, leaving -$13M of free cash flow.
Where are the figures from?
From Akso Health Group's annual and quarterly reports to the SEC, read from the structured data (XBRL) it files itself.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.